chr10-76885128-G-A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_001161352.2(KCNMA1):​c.*2138C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000784 in 1,452,862 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.00046 ( 2 hom., cov: 30)
Exomes 𝑓: 0.00082 ( 13 hom. )

Consequence

KCNMA1
NM_001161352.2 3_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.568

Publications

0 publications found
Variant links:
Genes affected
KCNMA1 (HGNC:6284): (potassium calcium-activated channel subfamily M alpha 1) This gene encodes the alpha subunit of calcium-activated BK channel. The encoded protein is involved in several physiological processes including smooth muscle contraction, neurotransmitter release and neuronal excitability. Mutations in this gene are associated with a spectrum of neurological disorders including Paroxysmal Nonkinesigenic Dyskinesia 3, Idiopathic Generalized Epilepsy 16 and Liang-Wang syndrome. [provided by RefSeq, Aug 2022]
KCNMA1 Gene-Disease associations (from GenCC):
  • generalized epilepsy-paroxysmal dyskinesia syndrome
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, G2P, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
  • Liang-Wang syndrome
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • cerebellar atrophy, developmental delay, and seizures
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 10-76885128-G-A is Benign according to our data. Variant chr10-76885128-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 879815.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000459 (69/150484) while in subpopulation EAS AF = 0.00877 (45/5130). AF 95% confidence interval is 0.00674. There are 2 homozygotes in GnomAd4. There are 35 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNMA1NM_001161352.2 linkc.*2138C>T 3_prime_UTR_variant Exon 28 of 28 ENST00000286628.14 NP_001154824.1 Q12791-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNMA1ENST00000286628.14 linkc.*2138C>T 3_prime_UTR_variant Exon 28 of 28 1 NM_001161352.2 ENSP00000286628.8 Q12791-1

Frequencies

GnomAD3 genomes
AF:
0.000459
AC:
69
AN:
150400
Hom.:
2
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0000731
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000663
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00875
Gnomad SAS
AF:
0.000209
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000280
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.000822
AC:
1070
AN:
1302378
Hom.:
13
Cov.:
27
AF XY:
0.000817
AC XY:
521
AN XY:
637898
show subpopulations
African (AFR)
AF:
0.0000702
AC:
2
AN:
28488
American (AMR)
AF:
0.0000774
AC:
2
AN:
25838
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
21956
East Asian (EAS)
AF:
0.0262
AC:
843
AN:
32222
South Asian (SAS)
AF:
0.000214
AC:
13
AN:
60720
European-Finnish (FIN)
AF:
0.0000238
AC:
1
AN:
42028
Middle Eastern (MID)
AF:
0.000188
AC:
1
AN:
5316
European-Non Finnish (NFE)
AF:
0.000178
AC:
184
AN:
1032112
Other (OTH)
AF:
0.000447
AC:
24
AN:
53698
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
44
88
131
175
219
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000459
AC:
69
AN:
150484
Hom.:
2
Cov.:
30
AF XY:
0.000476
AC XY:
35
AN XY:
73460
show subpopulations
African (AFR)
AF:
0.0000729
AC:
3
AN:
41154
American (AMR)
AF:
0.0000662
AC:
1
AN:
15110
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3462
East Asian (EAS)
AF:
0.00877
AC:
45
AN:
5130
South Asian (SAS)
AF:
0.000210
AC:
1
AN:
4762
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9848
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
282
European-Non Finnish (NFE)
AF:
0.000280
AC:
19
AN:
67742
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.518
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000196
Hom.:
0
Bravo
AF:
0.000608
Asia WGS
AF:
0.00289
AC:
10
AN:
3474

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Generalized epilepsy-paroxysmal dyskinesia syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
0.71
DANN
Benign
0.57
PhyloP100
-0.57
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77051509; hg19: chr10-78644886; API